HFA Premium Access

RAASi therapy benefit and challenges in cardio-renal patients.

Presentation

About the speaker

Professor Lars Lund

Karolinska Institute, Stockholm (Sweden)
46 presentations
1 follower

5 more presentations in this session

Welcome and introduction.

Thumbnail

Treatment strategies to manage hyperkalemia and control potassium levels.

Speaker: Professor S. Anker (Berlin, DE)

Thumbnail

Changing the treatment paradigm of hyperkalemia management to enable and optimize RAASi therapy.

Speaker: Professor J. Butler (Jackson, US)

Thumbnail

Panel discussion.

Speaker: Professor B. Pitt (Ann Arbor, US)

Thumbnail

Summary and conclusions.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Thumbnail

Access the full session

Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels

Speakers: Professor L. Lund, Professor S. Anker, Professor J. Butler, Professor B. Pitt, Professor F. Zannad
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk